Clinical trials
Type 1 Diabetes Mellitus With Hypoglycemia clinical trials
Below are recruiting type 1 diabetes mellitus with hypoglycemia clinical trials, each written for real people, not researchers. We’re tracking 86 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06676657Recruiting
Closed loop with context-aware insulin delivery for type 1 diabetes
This study tests a smart insulin pump system that adjusts automatically during exercise. It aims to make managing blood sugar easier and safer.
Portland, OregonAges 18–100 - NCT07347080RecruitingEarly Phase 1
Study of a new RNA-based drug for type 2 diabetes
This trial tests an experimental injection (CR059) for type 2 diabetes. It looks at safety and how the body handles different doses. You may qualify if you have had diabetes for 3 months to 5 years and are currently managing it with diet/exercise or certain diabetes pills.
Luoyang, HenanAges 18–65 - NCT05164263RecruitingPhase 4
Testing empagliflozin for adults with type 2 diabetes on tablets
This study looks at how well and how safely empagliflozin works in real-world care for adults with type 2 diabetes who are not controlled on current pill treatment. Some participants take it with metformin, and the study helps confirm what to expect in everyday patients.
Kabul, AfghanistanAges 18–65 - NCT07693036RecruitingPhase 1/Phase 2
Exosomes from stem cells for type 2 diabetes
This trial tests if a type of stem cell product (exosomes) can safely and effectively help people with type 2 diabetes. Researchers will give infusions to see if it improves blood sugar control and pancreatic function.
BeijingAges 18–65 - NCT07128186Recruiting
AI predicts memory decline in type 2 diabetes
This study uses an AI tool to predict memory problems in people with type 2 diabetes. It may help catch early signs of cognitive decline and guide future care.
Enshi, HubeiAges 40–75 - NCT07296484RecruitingPhase 2
Clofutriben for hard-to-control type 2 diabetes
This trial tests a new medication, clofutriben, for people with hard-to-control type 2 diabetes who might also have mild excess of a stress hormone called cortisol. It aims to see if the drug can help lower blood sugar and improve diabetes management.
Chandler, ArizonaAges 18 years+ - NCT07502495RecruitingPhase 2
Icovamenib for type 2 diabetes not reaching glucose goals
This study tests an investigational pill called icovamenib for people with type 2 diabetes who have not reached their blood sugar targets with current medications. It aims to see if the drug can help improve blood sugar control.
Birmingham, AlabamaAges 18–75 - NCT06764069Recruiting
New sensor for continuous blood sugar monitoring
This study tests a new glucose sensor placed inside a blood vessel to see how well it measures blood sugar. If you have diabetes and use intensive insulin therapy, this could be a way to help improve monitoring.
São Paulo, BrazilAges 21–75 - NCT06883682Recruiting
ECG sticker for checking blood sugar
This study tests a new way to measure blood sugar using an ECG (heart signal) sticker. It may help people with diabetes, chronic kidney disease, or those without diabetes monitor their glucose without finger sticks.
TaoyuanAges 18 years+ - NCT07399678RecruitingPhase 1
A study of ALV-100 for overweight people with or without type 2 diabetes
This trial tests a new medication called ALV-100 for safety and how well it works in people who are overweight or have type 2 diabetes. It might help if you have a higher body weight and want to try a new treatment option.
Miami, FloridaAges 18–65 - NCT05354947Recruiting
Ultrasound test in adults with type 2 diabetes
This study tests whether a series of ultrasound treatments can improve blood sugar control in people with type 2 diabetes. You may be asked to stay on your current diabetes pills and avoid certain other medicines during the study.
New Haven, ConnecticutAges 21–75 - NCT05708859RecruitingPhase 4
Tirzepatide to slow plaque buildup in coronary arteries
This trial studies tirzepatide to see if it can slow the progression of coronary artery plaque in people with type 2 diabetes. It uses special heart CT scans to track changes over time.
Torrance, CaliforniaAges 40–80 - NCT06558708RecruitingPhase 2
Comparing two once-daily insulins for type 2 diabetes
This trial compares two once-daily insulin injections to see which works better and is safer for people with type 2 diabetes. Both are new types of insulin designed to help control blood sugar with fewer side effects.
TianjinAges 18–75 - NCT07146347RecruitingPhase 1
Comparing a new long-acting insulin for type 2 diabetes
This study tests a new once-daily insulin (GZR4) against an approved insulin (degludec) in people with type 2 diabetes to see how well it controls blood sugar. You may qualify if you are already using a stable dose of background insulin.
NeussAges 18–70
Hear when a new Type 1 Diabetes Mellitus With Hypoglycemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for type 1 diabetes mellitus with hypoglycemia?
- Yes. Clin2 currently lists 86 recruiting type 1 diabetes mellitus with hypoglycemia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a type 1 diabetes mellitus with hypoglycemia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a type 1 diabetes mellitus with hypoglycemia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.